Tweet
Very interesting news
-
-
I saw that too
I did some digging around, not a lot of new info out there yet but I did find this.
-
A bit more illumination on this dark horse:
The company site
Speculative article at Genomes Unzipped
They're scheduled for a talk at AGBT on Saturday (the shiny new toy session). Rack based set-up, real time tweakability.
Sequence until... Sufficient. I love it!Comment
-
Agbt
Hello - saw your post and thank you. Oxford Nanopore isn't actually on the agenda at this year's AGBT. There are talks through from our academic collaborators about the nanopore research being conducted in their labs, which we hope you will find of interest. Enjoy AGBT!Comment
-
Well huh.
Given the founder of the company is talking and what session it's in I thought there might be something exciting going on... Definitely looking forward to it, anyways.Comment
-
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...09-09-2024, 10:59 AM -
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...08-27-2024, 04:44 AM
Comment